Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Melatonin reverses H-89 induced spatial memory deficit: Involvement of oxidative stress and mitochondrial function.
Nano-particle delivery of brain derived neurotrophic factor after focal cerebral ischemia reduces tissue injury and enhances behavioral recovery.
High-Resolution Expression Profiling of Peripheral Blood CD8(+) Cells in Patients with Multiple Sclerosis Displays Fingolimod-Induced Immune Cell Redistribution.
Disease activity in chronic inflammatory demyelinating polyneuropathy.
Evolution of Myelin Proteins.
Hippocampal microstructural damage correlates with memory impairment in clinically isolated syndrome suggestive of multiple sclerosis.
Interferon-β therapy specifically reduces pathogenic memory B cells in Multiple Sclerosis patients by inducing a FAS-mediated apoptosis.
Observational data: Understanding the real MS world.
Severe tumefactive rebound of multiple sclerosis following fingolimod cessation.
Peripheral Nerve Ultrasonography in Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy: Correlations with Clinical and Neurophysiological Data.
Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4.
Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod.
Pathological relationships involving iron and myelin may constitute a shared mechanism linking various rare and common brain diseases.
Polyomaviruses.
T cell epitope spreading to myelin oligodendrocyte glycoprotein in HLA-DR4 transgenic mice during experimental autoimmune encephalomyelitis.
An unusual infection in MS patient treated with dimethyl fumarate: A case report of omphalitis.
Pur-Alpha Induces JCV Gene Expression and Viral Replication by Suppressing SRSF1 in Glial Cells.
Dopa-responsive acute disseminated encephalomyelitis with marked atrophy of the striate body.
Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study.
Health Literacy and Outcomes in Multiple Sclerosis.
Individual Differences in the Alignment of Structural and Functional Markers of the V5/MT Complex in Primates.
Transcellular spreading of huntingtin aggregates in the Drosophila brain.
MRI in the evaluation of pediatric multiple sclerosis.
Fingolimod suppresses bone resorption in female patients with multiple sclerosis.
Tolerance induction by bone marrow transplantation in a multiple sclerosis model.
Pages
« first
‹ previous
…
764
765
766
767
768
769
770
771
772
…
next ›
last »